28102508|t|Simvastatin Promotes Hematoma Absorption and Reduces Hydrocephalus Following Intraventricular Hemorrhage in Part by Upregulating CD36
28102508|a|We previously found that hematoma worsens hydrocephalus after intraventricular hemorrhage (IVH) via increasing iron deposition and aggravating ependymal cilia injury; therefore, promoting hematoma absorption may be a promising strategy for IVH. Recently, some investigations imply that simvastatin has the ability of accelerating hematoma absorption. Thus, this study was designed to examine the efficacy of simvastatin for IVH in rats. Intracerebral hemorrhage with ventricular extension was induced in adult male Sprague-Dawley rats after autologous blood injection. Simvastatin or vehicle was administered orally at 1 day after IVH and then daily for 1 week. MRI studies were performed to measure the volumes of intracranial hematoma and lateral ventricle at days 1, 3, 7, 14, and 28 after IVH. Motor and neurocognitive functions were assessed at days 1 to 7 and 23 to 28, respectively. Iron deposition, iron -related protein expression, ependymal damage, and histology were detected at day 28. Expression of CD36 scavenger receptor (facilitating phagocytosis) was examined at day 3 after IVH using western blotting and immunofluorescence. Simvastatin significantly increased hematoma absorption ratio, reduced ventricular volume, and attenuated neurological dysfunction post- IVH. In addition, less iron accumulation and more cilia survival was observed in the simvastatin group when compared with the control. What's more, higher expression of CD36 was detected around the hematoma after simvastatin administration. Simvastatin significantly enhanced brain hematoma absorption, alleviated hydrocephalus, and improved neurological recovery after experimental IVH, which may in part by upregulating CD36 expression. Our data suggest that early simvastatin use may be a novel therapy for IVH patients.
28102508	0	11	Simvastatin	T109,T121	C0074554
28102508	21	29	Hematoma	T046	C0018944
28102508	30	40	Absorption	T070	C0000854
28102508	53	66	Hydrocephalus	T047	C0020255
28102508	77	104	Intraventricular Hemorrhage	T046	C0240059
28102508	116	128	Upregulating	T044	C0041904
28102508	129	133	CD36	T028	C1366645
28102508	159	167	hematoma	T046	C0018944
28102508	168	175	worsens	T033	C1457868
28102508	176	189	hydrocephalus	T047	C0020255
28102508	196	223	intraventricular hemorrhage	T046	C0240059
28102508	225	228	IVH	T046	C0240059
28102508	234	244	increasing	T169	C0442808
28102508	245	260	iron deposition	T046	C0333596
28102508	277	286	ependymal	T024	C0014472
28102508	287	292	cilia	T026	C0008778
28102508	293	299	injury	T037	C3263723
28102508	322	330	hematoma	T046	C0018944
28102508	331	341	absorption	T070	C0000854
28102508	374	377	IVH	T046	C0240059
28102508	420	431	simvastatin	T109,T121	C0074554
28102508	464	472	hematoma	T046	C0018944
28102508	473	483	absorption	T070	C0000854
28102508	530	538	efficacy	T080	C1280519
28102508	542	553	simvastatin	T109,T121	C0074554
28102508	558	561	IVH	T046	C0240059
28102508	565	569	rats	T015	C0086893
28102508	571	595	Intracerebral hemorrhage	T046	C0475526
28102508	638	648	adult male	T032	C0086582
28102508	649	668	Sprague-Dawley rats	T015	C0034715
28102508	675	701	autologous blood injection	T061	C0849679
28102508	703	714	Simvastatin	T109,T121	C0074554
28102508	718	725	vehicle	T122	C0042444
28102508	730	749	administered orally	T061	C0001563
28102508	765	768	IVH	T046	C0240059
28102508	796	807	MRI studies	T060	C3515983
28102508	826	833	measure	T169	C0242485
28102508	838	845	volumes	T059	C2700258
28102508	849	861	intracranial	T029	C0524466
28102508	862	870	hematoma	T046	C0018944
28102508	875	892	lateral ventricle	T030	C0152279
28102508	927	930	IVH	T046	C0240059
28102508	932	937	Motor	T038	C0234130
28102508	942	966	neurocognitive functions	T038	C3714634
28102508	972	980	assessed	T052	C1516048
28102508	1024	1039	Iron deposition	T046	C0333596
28102508	1041	1045	iron	T121,T123,T196	C0302583
28102508	1055	1073	protein expression	T045	C1171362
28102508	1075	1091	ependymal damage	T033	C3686783
28102508	1097	1106	histology	T169	C4048239
28102508	1112	1120	detected	T033	C0442726
28102508	1132	1142	Expression	T045	C0017262
28102508	1146	1150	CD36	T028	C1366645
28102508	1151	1169	scavenger receptor	T116,T192	C0074129
28102508	1184	1196	phagocytosis	T043	C0031308
28102508	1202	1210	examined	T033	C0332128
28102508	1226	1229	IVH	T046	C0240059
28102508	1236	1252	western blotting	T059,T063	C0005863
28102508	1257	1275	immunofluorescence	T059	C0079603
28102508	1277	1288	Simvastatin	T109,T121	C0074554
28102508	1303	1312	increased	T081	C0205217
28102508	1313	1321	hematoma	T046	C0018944
28102508	1322	1332	absorption	T070	C0000854
28102508	1333	1338	ratio	T081	C0456603
28102508	1340	1347	reduced	T080	C0392756
28102508	1348	1366	ventricular volume	T078	C1511726
28102508	1372	1407	attenuated neurological dysfunction	T033	C1709219
28102508	1414	1417	IVH	T046	C0240059
28102508	1432	1454	less iron accumulation	T033	C4021076
28102508	1464	1469	cilia	T026	C0008778
28102508	1470	1478	survival	T081	C1709301
28102508	1499	1510	simvastatin	T109,T121	C0074554
28102508	1540	1547	control	T096	C0009932
28102508	1562	1568	higher	T080	C0205250
28102508	1569	1579	expression	T045	C0017262
28102508	1583	1587	CD36	T028	C1366645
28102508	1592	1600	detected	T033	C0442726
28102508	1612	1620	hematoma	T046	C0018944
28102508	1627	1638	simvastatin	T109,T121	C0074554
28102508	1639	1653	administration	T061	C1533734
28102508	1655	1666	Simvastatin	T109,T121	C0074554
28102508	1690	1695	brain	T023	C0006104
28102508	1696	1704	hematoma	T046	C0018944
28102508	1705	1715	absorption	T070	C0000854
28102508	1717	1741	alleviated hydrocephalus	T047	C0020255
28102508	1747	1755	improved	T033	C0184511
28102508	1756	1768	neurological	T080	C0205494
28102508	1769	1777	recovery	T040	C2004454
28102508	1784	1796	experimental	T080	C1517586
28102508	1797	1800	IVH	T046	C0240059
28102508	1823	1835	upregulating	T044	C0041904
28102508	1836	1840	CD36	T028	C1366645
28102508	1841	1851	expression	T045	C0017262
28102508	1857	1861	data	T078	C1511726
28102508	1881	1892	simvastatin	T109,T121	C0074554
28102508	1906	1911	novel	T080	C0205314
28102508	1912	1919	therapy	T061	C0087111
28102508	1924	1927	IVH	T046	C0240059
28102508	1928	1936	patients	T101	C0030705